KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Moderna (MRNA) Other Gross PP&E Adjustments (2017 - 2025)

Moderna (MRNA) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 10.37% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 10.37% year-over-year, with the annual reading at $2.0 billion for FY2025, 10.37% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $2.0 billion at Moderna, down from $2.1 billion in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $2.4 billion in Q3 2023, with the low at $408.0 million in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $1.6 billion, with a median of $1.8 billion recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments skyrocketed 200.68% in 2021, then decreased 11.35% in 2024.
  • Over 5 years, Other Gross PP&E Adjustments stood at $884.0 million in 2021, then soared by 64.93% to $1.5 billion in 2022, then increased by 6.58% to $1.6 billion in 2023, then rose by 17.95% to $1.8 billion in 2024, then rose by 10.37% to $2.0 billion in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $2.0 billion, $2.1 billion, and $2.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.